Lower open as crude oil retreats

Retreating crude oil prices weighed the markets down to a lower open with the Dow losing 19 points to 20,723. Nasdaq fell 14 points to 5,851.


On the upside


Microbes Medical (Nasdaq: MBOT) received a patent for a device that prevents shunt stenosis.


Garmin (Nasdaq: GRMN) reported higher fourth quarter earnings that topped analyst estimates.


Internap (Nasdaq: INAP) raised $43 million through a private placement.


On the downside


An independent data monitoring committee recommended that Argos Therapeutics (Nasdaq: ARGS) discontinue its Phase 3 ADAPT clinical trial of rocapuldencel-T for futility.


Profit taking weighed down shares of Eyegate Pharmaceuticals (Nasdaq: EYEG).

Parker Drilling (NYSE: PKD) priced its public offering of 12 million common shares at the discounted price of $2.10 per share.


The broader S&P 500 index slipped 4 points to 2,360. Bitcoin rose $4 to $1,110.


Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.